Your browser is no longer supported. Please, upgrade your browser.
Settings
PLSE Pulse Biosciences, Inc. daily Stock Chart
PLSE [NASD]
Pulse Biosciences, Inc.
Index- P/E- EPS (ttm)-1.99 Insider Own36.70% Shs Outstand17.68M Perf Week3.76%
Market Cap268.56M Forward P/E- EPS next Y- Insider Trans0.73% Shs Float7.62M Perf Month-17.36%
Income-31.00M PEG- EPS next Q- Inst Own9.30% Short Float24.68% Perf Quarter-18.81%
Sales- P/S- EPS this Y-100.40% Inst Trans-16.08% Short Ratio10.25 Perf Half Y-41.53%
Book/sh2.44 P/B6.23 EPS next Y- ROA-70.30% Target Price- Perf Year-42.24%
Cash/sh1.89 P/C8.04 EPS next 5Y- ROE-77.00% 52W Range9.81 - 39.50 Perf YTD-35.64%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-61.54% Beta-
Dividend %- Quick Ratio15.40 Sales past 5Y- Gross Margin- 52W Low54.83% ATR1.56
Employees33 Current Ratio15.40 Sales Q/Q- Oper. Margin- RSI (14)43.52 Volatility8.05% 9.06%
OptionableYes Debt/Eq0.00 EPS Q/Q-122.10% Profit Margin- Rel Volume0.67 Prev Close15.22
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume183.63K Price15.19
Recom- SMA20-11.70% SMA50-8.76% SMA200-25.14% Volume123,054 Change-0.20%
May-16-18 04:00PM  Pulse Biosciences Grants Equity Incentive Awards to New Employees Business Wire +8.74%
May-08-18 04:28PM  Pulse Biosciences Quarterly Investor Conference Call Business Wire
Apr-30-18 04:01PM  Pulse Biosciences to Report First Quarter 2018 Financial Results and Operational Highlights Business Wire
Apr-18-18 04:00PM  Pulse Biosciences Grants Equity Incentive Awards to New Employee Business Wire
Apr-13-18 04:32PM  Why Alaska Air Group, Pulse Biosciences, and BJ's Restaurants Jumped Today Motley Fool +10.56%
08:30AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
07:48AM  Pulse Biosciences stock soars to lead premarket gainers after positive study results MarketWatch
Apr-12-18 05:19PM  Pulse Biosciences Announces Positive Results from Its First Study Evaluating a Clinical Target at Major Scientific Meeting Business Wire
Mar-21-18 04:00PM  Pulse Biosciences Grants Equity Incentive Awards to New Employees Business Wire
Mar-16-18 04:00PM  Pulse Biosciences Quarterly Investor Conference Call Business Wire
09:30AM  Pulse Biosciences, Inc. to Host Earnings Call ACCESSWIRE
06:54AM  Is Pulse Biosciences Incs (NASDAQ:PLSE) CEO Incentives Align With Yours? Simply Wall St.
Mar-08-18 01:45PM  Pulse Biosciences to Report Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights Business Wire
Feb-20-18 07:30AM  Consolidated Research: 2018 Summary Expectations for RealPage, Briggs & Stratton, Genesis Energy, Synchrony Financial, Pulse Biosciences, and Ally Financial Fundamental Analysis, Key Performance Indications GlobeNewswire
Dec-19-17 07:10AM  Blog Exposure - Pulse Biosciences Grants Equity Inducement Awards to Its New Employees ACCESSWIRE
Dec-15-17 08:32PM  Pulse Biosciences Grants Equity Inducement Awards to New Employees Business Wire
Dec-14-17 08:05AM  Does Pulse Biosciences Incs (NASDAQ:PLSE) CEO Pay Reflect Performance? Simply Wall St.
Dec-04-17 08:05AM  New Research: Key Drivers of Growth for Synchrony Financial, Pulse Biosciences, Ally Financial, RealPage, Briggs & Stratton, and Genesis Energy Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Nov-07-17 04:22PM  Pulse Biosciences Quarterly Investor Conference Call Business Wire
10:00AM  Pulse Biosciences, Inc. to Host Earnings Call ACCESSWIRE
Nov-06-17 07:10AM  Corporate News Blog - Medical Technology Company Pulse Biosciences Announces Changes to its Board ACCESSWIRE +9.22%
Nov-03-17 08:00AM  Pulse Biosciences Announces Transition of Board of Directors, Extends Appreciation to Retiring Members and Welcomes New Board Members Business Wire
07:50AM  Detailed Research: Economic Perspectives on Discover Financial, Pulse Biosciences, The Travelers Companies, Xylem, Cheniere Energy Partners, and Cheniere Energy What Drives Growth in Today's Competitive Landscape GlobeNewswire
Oct-24-17 05:00PM  Pulse Biosciences to Host Quarterly Investor Conference Call on November 7, 2017 Business Wire
Oct-15-17 01:37PM  Healthcare Industry Trends And Its Impact On Pulse Biosciences Inc (PLSE) Simply Wall St.
Sep-25-17 08:00AM  Pulse Biosciences Announces $30 Million Private Placement Business Wire +24.43%
Sep-11-17 03:37PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Pulse Biosciences, Inc. Business Wire -21.00%
02:20PM  Glancy Prongay & Murray LLP Commences Investigation on Behalf of Pulse Biosciences, Inc. Investors (PLSE) Business Wire
12:38PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Pulse Biosciences, Inc. (PLSE) PR Newswire
11:17AM  EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Pulse Biosciences, Inc. Business Wire
08:00AM  Pulse Biosciences Announces Withdrawal and Planned Resubmission of 510(k) Application for the PulseTxTM System Business Wire
Jul-27-17 04:00PM  Pulse Biosciences Quarterly Investor and Analyst Conference Call Business Wire -7.33%
11:00AM  Investor Network: Pulse Biosciences, Inc. to Host Earnings Call ACCESSWIRE
Jul-11-17 07:30PM  Pulse Biosciences to Host Quarterly Investor Conference Call on July 27, 2017 Business Wire
Jun-06-17 08:00AM  Pulse Biosciences Announces Treatment of First Patient in Study to Evaluate the Safety and Efficacy of Novel Nano-Pulse Stimulation Technology for Seborrheic Keratosis Lesions Business Wire
May-07-17 10:39PM  Edited Transcript of PLSE earnings conference call or presentation 4-May-17 8:30pm GMT Thomson Reuters StreetEvents
May-04-17 01:30PM  Pulse Biosciences Quarterly Investor Conference Call Business Wire
10:00AM  Investor Network: Pulse Biosciences, Inc. to Host Earnings Call Accesswire
Apr-17-17 06:34PM  Pulse Biosciences to Host Quarterly Investor Conference Call on May 4, 2017 Business Wire +10.06%
Mar-27-17 09:30AM  Xenon Pharmaceuticals Falls as Acne Drug Fails Study, Pulse Biosciences Submits 510(k) to FDA Accesswire +9.82%
Mar-26-17 10:25AM  Insider Buying Jumps as Market Volatility Grows: Sears, IFF, Pulse Biosciences, PRA Group, Radius Health and More
Mar-24-17 01:04PM  PULSE BIOSCIENCES, INC. Financials +17.19%
Mar-23-17 01:08PM  Insiders Load Up on Pulse Biosciences GuruFocus.com
Mar-20-17 05:17PM  PULSE BIOSCIENCES, INC. Files SEC form 10-K, Annual Report -5.96%
Mar-14-17 04:30PM  Pulse Biosciences Inc Earnings Call scheduled for 4:30 pm ET today
04:20PM  PULSE BIOSCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
04:00PM  Pulse Biosciences Quartery Investor Conference Call Business Wire
08:30AM  Pulse Biosciences Submits 510(k) Application to FDA for PulseTx System Business Wire
07:07AM  Q4 2016 Pulse Biosciences Inc Earnings Release - Time Not Supplied
Mar-01-17 04:46PM  Pulse Biosciences to Host Investor Conference Call on March 14, 2017 Business Wire
Feb-23-17 01:11PM  StreetSweeper's New Short: Pulse Biosciences Benzinga
Feb-22-17 05:31PM  Heres where a Pinellas billionaire and top donor to Church of Scientology is putting his investment dollars at bizjournals.com
05:31PM  Heres where a Pinellas billionaire and top donor to Church of Scientology is putting his investment dollars American City Business Journals
Feb-21-17 05:13PM  PULSE BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Feb-10-17 09:24AM  PULSE BIOSCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity S +23.84%
08:30AM  Pulse Biosciences Announces Healthcare Executives and Entrepreneurs Robert Duggan and Dr. Maky Zanganeh Have Acquired a Combined Interest of 17.1% of the Company Business Wire
Jan-27-17 03:53PM  PULSE BIOSCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
Nov-14-16 04:01PM  PULSE BIOSCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition
04:00PM  Pulse Biosciences Quarterly Nano-Pulse Stimulation (NPS) Update Business Wire
08:00AM  Pulse Biosciences Announces First Clinical Use of the Proprietary PulseTx Platform in a Pilot Study in Dermatology Business Wire
Nov-11-16 08:00AM  Pulse Biosciences Announces New Data That Reinforce Potential Immuno-Oncology Benefits of Nano-Pulse Stimulation Technology Business Wire
Nov-02-16 03:00PM  Pulse Biosciences to Host Third Quarter Investor Conference Call on November 14, 2016 Business Wire
Oct-18-16 08:00AM  Pulse Biosciences to Present New Data at the Society for Immunotherapy in Cancer Annual Meeting Business Wire
Aug-24-16 04:00PM  Pulse Biosciences Appoints Edward Ebbers as Vice President and General Manager of Dermatology Products Business Wire
Pulse Biosciences, Inc., a clinical-stage medical technology company, develops therapeutic tissue treatment platform based on its proprietary nano-pulse stimulation (NPS) technology. Its NPS is a non-thermal, precise, and focal drug-free tissue treatment technology that initiates cell death within treated tissue used in oncology, dermatology/aesthetics, minimally invasive, and veterinary applications. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was founded in 2014 and is headquartered in Hayward, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DUGGAN ROBERT WDirectorMay 11Buy23.1621,353494,5355,862,422May 15 08:07 PM
Zanganeh MakyDirectorDec 13Buy23.981,10026,37895,574Dec 15 04:19 PM
DUGGAN ROBERT WDirectorDec 13Buy22.4420,556461,2775,841,069Dec 13 09:49 PM
Zanganeh MakyDirectorDec 12Buy23.981,00023,97994,474Dec 13 08:30 PM
Zanganeh MakyDirectorDec 11Buy22.763,00068,28993,474Dec 13 08:30 PM
DUGGAN ROBERT W10% OwnerOct 19Buy22.7922,901521,8685,820,513Oct 23 04:43 PM
DUGGAN ROBERT W10% OwnerSep 24Buy15.022,000,00030,040,0005,797,612Sep 26 06:32 PM
Zanganeh MakyDirectorSep 18Buy15.027,775116,791332,500Sep 18 09:07 PM
DUGGAN ROBERT W10% OwnerSep 18Buy15.2131,200474,4583,797,612Sep 18 09:06 PM
DUGGAN ROBERT W10% OwnerSep 15Buy15.22197,0983,000,7103,766,412Sep 18 09:06 PM
Zanganeh MakyDirectorSep 14Buy12.7722,000280,879324,725Sep 18 09:07 PM
DUGGAN ROBERT W10% OwnerSep 14Buy13.27181,6202,409,9353,569,314Sep 18 09:06 PM
Levinson Mitchell E.DirectorSep 14Buy12.303,83547,1702,500Sep 18 09:06 PM
DUGGAN ROBERT W10% OwnerAug 03Buy23.7068,9641,634,7233,387,694Aug 03 07:36 PM
Zanganeh MakyDirectorAug 03Buy23.005,000115,01590,474Aug 04 05:46 PM
Zanganeh MakyDirectorAug 03Buy23.6315,500366,317302,725Aug 04 05:46 PM
DUGGAN ROBERT W10% OwnerAug 02Buy24.9153,0001,320,3953,318,730Aug 03 07:36 PM
Zanganeh MakyDirectorAug 02Buy25.158,290208,469287,225Aug 04 05:46 PM
DUGGAN ROBERT W10% OwnerAug 01Buy22.28155,4863,464,2003,265,730Aug 03 07:36 PM
DUGGAN ROBERT W10% OwnerMay 23Buy27.2949,2001,342,7063,110,244May 24 08:03 PM